BioArctic AB (publ) (STO:BIOA.B)
321.60
-2.60 (-0.80%)
Dec 16, 2025, 3:08 PM CET
BioArctic AB Employees
BioArctic AB had 107 employees as of December 31, 2024. The number of employees increased by 19 or 21.59% compared to the previous year.
Employees
107
Change (1Y)
19
Growth (1Y)
21.59%
Revenue / Employee
15.71M SEK
Profits / Employee
8.19M SEK
Market Cap
28.21B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 107 | 19 | 21.59% |
| Dec 31, 2023 | 88 | 27 | 44.26% |
| Dec 31, 2022 | 61 | 12 | 24.49% |
| Dec 31, 2021 | 49 | 4 | 8.89% |
| Dec 31, 2020 | 45 | 3 | 7.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Medicover AB | 47,256 |
| Getinge AB | 11,791 |
| Nolato AB | 5,837 |
| Elekta AB | 4,556 |
| Asker Healthcare Group AB | 4,030 |
| AddLife AB | 2,181 |
| Swedish Orphan Biovitrum AB | 1,806 |
| Sectra AB | 1,296 |
BioArctic AB News
- 7 days ago - Leqembi included in China's commercial insurance innovative drug list - PRNewsWire
- 12 days ago - New Leqembi-data presented at CTAD 2025 suggests potential to delay disease progression by up to 8.3 years with continued treatment - PRNewsWire
- 18 days ago - Eisai Announces Filing Of New Drug Application For Leqembi In Japan - Nasdaq
- 27 days ago - New data on lecanemab to be presented at CTAD conference - PRNewsWire
- 4 weeks ago - BioArctic AB (publ) 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - Leqembi® approved for IV maintenance treatment in the United Kingdom - PRNewsWire
- 4 weeks ago - BioArctic AB (publ) (BRCTF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - BioArctic AB (BRCTF) Q3 2025 Earnings Call Highlights: Strategic Partnerships and R&D Drive ... - GuruFocus